Jazz Pharmaceuticals plc (JAZZ) Q3 2024 Earnings Call

Investor webinar replay

Replay transcript excerpt

Thank you, Operator, and good afternoon, everyone. Today, Jazz Pharmaceuticals reported its third quarter 2024 financial results. The slide presentation accompanying this webcast is available on the Investors section of our website. Investors may also refer to the press release we issued earlier today, which is also posted to our website. On the call today are Bruce Kozad, Chairman and Chief Executive Officer, Rene Gauland, President and Chief Operating Officer, Rob Yannone, Executive Vice President, Global Head of R&D, and Phil Johnson, Chief Financial Officer. On slide two, I'd like to remind you that today's webcast includes forward-looking statements, such as those related to our future financial and operating results, growth potential, and anticipated development and commercialization milestones and goals, which involve risks and uncertainties that could cause actual events, performance, and results to differ materially from those contained in these forward-looking statements. We encourage you to review the statements contained in today's press release in our slide deck and the risks and uncertainties described in our SEC filings. which identifies certain factors that may cause the company's actual events, performance, and results to differ materially from those contained in the forward-looking statements made on today's webcast. We undertake no duty or obligation to update our forward-looking statements. As noted on slide three, we will discuss non-GAAP financial measures on this webcast, descriptions of these non-GAAP financial measures, and reconciliations of GAAP to non-GAAP financial measures. are included in today's press release and the slide presentation available on the Investors section of our website. I'll now turn the call over to Bruce. Thanks, Andr...